Haltlose

Haltlose personality disorder is a condition classified in the ICD-10 under the code F60.8. It is characterized by certain features such as a lack of self-reliance, an intense desire for approval, and an excessive need for reassurance.

Symptoms[edit | edit source]

The primary symptoms of Haltlose personality disorder include a lack of self-reliance and an excessive need for approval and reassurance. Individuals with this disorder often have difficulty making decisions and may rely heavily on others for guidance. They may also have a strong desire to please others and may go to great lengths to gain approval, even if it means sacrificing their own needs or desires.

Diagnosis[edit | edit source]

Diagnosis of Haltlose personality disorder is typically made by a psychiatrist or psychologist through a comprehensive evaluation. This may include a thorough interview, a review of the individual's medical and psychiatric history, and possibly psychological testing. The diagnosis is made based on the presence of the characteristic symptoms and the exclusion of other mental health disorders.

Treatment[edit | edit source]

Treatment for Haltlose personality disorder typically involves psychotherapy, specifically cognitive behavioral therapy (CBT). CBT can help individuals with this disorder learn to identify and change unhealthy thought patterns and behaviors. In some cases, medication may also be used to help manage symptoms.

Prognosis[edit | edit source]

The prognosis for individuals with Haltlose personality disorder varies. With appropriate treatment, many individuals with this disorder can learn to manage their symptoms and lead fulfilling lives. However, without treatment, the disorder can significantly impact an individual's quality of life.

See also[edit | edit source]

Haltlose Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.